References for this review were identified by searches of Medline, ISI WebofScience, and references from relevant articles; additional articles were identified through searches of the extensive files of the authors. Search terms used in combination were “antimicrobial resistance”, “antibiotic resistance”, “antimicrobial use”, “antibiotic use”, “developing countries”, “Africa”, “Asia”, “Latin America”, “South America”, and “intervention”.
ReviewAntimicrobial resistance in developing countries. Part II: strategies for containment
Introduction
Antimicrobial resistance contributes to health and economic losses worldwide.1, 2 In developing countries, a high infectious disease burden commonly co-exists with rapid emergence and spread of microbial resistance. As indicated in part I of this review—published last month—the prevalence of resistance in seminal developing country pathogens is high and rising.3 Addressing the serious threat from resistant bacteria will require strategies for preventing the emergence of resistance, as well as containing resistant organisms that have already emerged.4 Most of the studies evaluating such strategies have been conducted within hospitals and other closed environments, predominantly in western Europe and North America, within well-functioning health-care systems. The structure and effectiveness of developing country health-care systems varies tremendously and therefore a one-size-fits-all model is neither useful nor desirable. Implicit from this variation is the need for area-specific surveillance to inform policy. Almost all developing countries have been insufficiently studied, but there are some areas, notably francophone Africa, the Pacific, and newly independent Soviet states, from which few or no data are available.5 Seemingly rational interventions do not always affect the prevalence of resistant microbes or alter practices that contribute to the emergence and spread of resistant organisms. Because there is no guarantee that untested interventions will be effective, particularly over the long term,6, 7, 8 pilot programmes to evaluate interventions should precede large-scale implementation.
Section snippets
Risk factors for resistance emergence and spread, particularly in developing countries
A summary of risk factors for resistance particularly pertinent to, but not limited to, developing countries is outlined in panel 1. Antimicrobial use produces selective pressure for resistance, and there is evidence to suggest that the number of patients consuming antimicrobials in developing countries is rising.9 Much of this increase is due to rising incomes and improved access to health care—both positive developments—and to changing disease patterns, such as opportunistic infections in
Interfering with the spread of resistant microorganisms in the community
A reduction in resistant S pneumoniae infections was seen in the USA following the introduction of a multivalent vaccine that protected against the serovars with which resistance is commonly associated.36 By contrast, Arason and colleagues8 found that, in Iceland, a fall in antibiotic use was unable to produce a sustainable effect on resistance. The use of pneumococcal vaccines could potentially achieve similar results in developing countries where only a few serotypes account for most
Educational interventions
The implementation of educational interventions is typically affordable for developing countries because the principal requirement is locally sourced manpower rather than expensive, typically imported, material inputs.18 Educational interventions that fail to change the prescribing behaviour of a sufficiently large proportion of prescribers can be reinforced through multiple interventions.47, 48 Integrating pharmacotherapy modules into standard medical and allied health curricula has been shown
Support and partnerships for antimicrobial resistance interventions and research
WHO published its Global strategy for containment of antimicrobial resistance report in 2001 in response to a growing problem.16 Broadly, the report recommends reducing the infectious disease burden, improving access to and use of antimicrobials, strengthening surveillance capabilities and other aspects of health-care systems, enforcing regulations, and developing new preventive and therapeutic medications.16 For developing countries, with constrained budgets that demand prioritisation, very
Search strategy and selection criteria
References (181)
- et al.
Antimicrobial resistance in developing countries. Part I: recent trends and current status
Lancet Infect Dis
(2005) - et al.
Improving antibiotic use in low-income countries: an overview of evidence on determinants
Soc Sci Med
(2003) - et al.
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study
Lancet
(2000) - et al.
On the implications of endogenous resistance to medications
J Health Econ
(2002) - et al.
Improving drug use through continuing education: a randomized controlled trial in Zambia
J Clin Epidemiol
(1996) - et al.
Small group intervention vs formal seminar for improving appropriate drug use
Soc Sci Med
(1996) - et al.
Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana
Soc Sci Med
(2002) - et al.
Malaria chemoprophylaxis compliance in pregnant women: a cost-effectiveness analysis of alternative interventions
Soc Sci Med
(1993) - et al.
Factors influencing physicians' prescribing behaviour in the treatment of childhood diarrhoea: knowledge may not be the clue
Soc Sci Med
(1996) - et al.
Infection control strategies in a neonatal intensive care unit in Argentina
J Hosp Infect
(1998)
Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance
Lancet Infect Dis
Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991–1998
Int J Infect Dis
Effect of washing hands with soap on diarrhoea risk in the community: a systematic review
Lancet Infect Dis
Sustained improvements in hygiene behaviour amongst village women in Lombok, Indonesia
Trans R Soc Trop Med Hyg
An interrupted time series analysis of parenteral antibiotic use in Colombia
J Clin Epidemiol
Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study
Lancet
Interactional group discussion: results of a controlled trial using a behavioral intervention to reduce the use of injections in public health facilities
Soc Sci Med
Improving physician prescribing patterns to treat rhinopharyngitis. Intervention strategies in two health systems of Mexico
Soc Sci Med
Impact of an educational program on antibiotic use in a tertiary care hospital in a developing country
J Clin Epidemiol
Improving private pharmacy practice: a multi-intervention experiment in Hanoi, Vietnam
J Clin Epidemiol
Effect of training on the clinical management of malaria by medical assistants in Ghana
Soc Sci Med
Purchase of antibiotics without prescription on Manila, the Phillipines
J Clin Epidemiol
Reported and actual prescription of oral rehydration therapy for childhood diarrhoeas by retail pharmacists in Nigeria
Soc Sci Med
The use of antimicrobial drugs in Nagpur, India. A window on medical care in a developing country
Soc Sci Med
Antimicrobial control programs
Semin Perinatol
Evaluation of antibiotic use in a hospital with an antibiotic restriction policy
Int J Antimicrob Agents
Implementation of clinical practice guidelines for upper respiratory infection in Thailand
Int J Infect Dis
Antibiotic noncompliance and waste in upper respiratory infections and acute diarrhea
J Clin Epidemiol
Monitoring and management of bacterial resistance to antibmicrobial agents: a World Health Organization Symposium, Geneva, Switzerland, 29th November–2nd December, 1994
Clin Infect Dis
Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype Typhimurium infections
J Infect Dis
Interventions against antimicrobial resistance
Improving parent knowledge about antibiotics: a video intervention
Pediatrics
Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska
Clin Infect Dis
Clonal spread of resistant pneumococci despite diminished antimicrobial use
Microb Drug Resist
Antibiotic resistance: consequences of inaction
Clin Infect Dis
Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine
J Infect Dis
Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia
Clin Infect Dis
Antibiotic resistance in developing countries
Risk factors for fecal quinolone-resistant Escherichia coli in Mexican children
Antimicrob Agents Chemother
High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission
Pediatrics
Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates
Pediatr Infect Dis J
Implementation workshop on the WHO global strategy for containment of antimicrobial resistance
Prioritsing interventions to contain antimicrobial resistance
Essential Drugs Monitor
Drug resistance
Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi
J Infect Dis
Evaluating treatment protocols to prevent antibiotic resistance
Proc Natl Acad Sci USA
DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India
Int J Tuberc Lung Dis
Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis
Science
Improving antimicrobial use among health workers in first-level facilities: results from the multi-country evaluation of the Integrated Management of Childhood Illness strategy
Bull World Health Organ
Cited by (213)
Synthesis and biological evaluation of coumarin appended thiazole hybrid heterocycles: Antibacterial and antifungal study
2023, Journal of Molecular StructurePhysicians’ attitudes, knowledge, and practices regarding antibiotic prescriptions
2023, Journal of Global Antimicrobial ResistanceGlobal trend of antimicrobial resistance in common bacterial pathogens in response to antibiotic consumption
2023, Journal of Hazardous MaterialsCitation Excerpt :Thus, in LMICs, the first priority will be antimicrobial stewardship and infection control rather than reducing antibiotic consumption to contain the emergence and spread of resistant bacterial pathogens. Thus, the successful experiences in antibiotic stewardship and infection control strategies (e.g., improving nonprescription antimicrobial use, educational interventions, legislation for antibiotic drug advertising, investments in improved hygiene, sanitation, vaccination, and hand hygiene) in HICs could provide models in LMICs (Apisarnthanarak and Mundy, 2008; Bavestrello et al., 2002; Bi et al., 2000; Cairncross, 2003; Chow and Szeto, 2003; Goossens et al., 2007, 2006; Guyon et al., 1994; Harbarth and Samore, 2005; Hawkey, 2008; Kumarasamy et al., 2010; Lawes et al., 2015; Laxminarayan et al., 2016; Lee et al., 2014a; Mölstad et al., 2008; Morgan et al., 2011; Okeke et al., 2005; Park et al., 2005; Poehling et al., 2004; Reyes et al., 1997; Rossolini et al., 2008; Sabuncu et al., 2009; Tängdén et al., 2010; Walsh et al., 2011; Whitney et al., 2003; Woloshin et al., 2001). However, the priorities and combinations of those interventions should still be determined at the local level of LMICs given the national infectious disease burdens, resistance patterns, and economic level.
Changing food systems and infectious disease risks in low-income and middle-income countries
2022, The Lancet Planetary Health